ESTA
Get informed when a big investor buys or sells
+ FollowOvervalued by 191.4% based on the discounted cash flow analysis.
| Market cap | $2.59 Billion |
|---|---|
| Enterprise Value | $2.53 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.72 |
| Beta | 1.07 |
| Outstanding Shares | 29,622,101 |
| P/E Ratio | -59.55 |
|---|---|
| PEG | 168.29 |
| Price to Sales | 12.37 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 11.01 |
| Enterprise Value to EBIT | -84.79 |
| Enterprise Value to Net Income | -58 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 59.95% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.54%▼ 89.81% |
|---|---|
| Total Invested | $13.82M▼ 99.09% |
| Investors Holding | 4▼ 185.00% |
No data
Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...